NCT02640430View on ClinicalTrials.gov

Randomized Trial of the FreeAspire Versus PEP-bottle After Acute Exacerbation in COPD Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

December 31, 2018

Conditions
COPD
Interventions
DEVICE

standard treatment

20 minutes, twice a day for 10 sessions

DEVICE

Free Aspire

20 minutes, twice a day for 10 sessions

Trial Locations (2)

6980

Division of Internal and Respiratory Medicine, Ospedale Malcantonese, Fondazione Giuseppe Rossi, Castelrotto

21049

Maugeri Foundation, Tradate

Sponsors

Lead Sponsor

Maugeri Foundation
All Listed Sponsors
lead

Maugeri Foundation

OTHER

NCT02640430 - Randomized Trial of the FreeAspire Versus PEP-bottle After Acute Exacerbation in COPD Patients | Biotech Hunter | Biotech Hunter